Endocrine Abstracts

Objectives: Somatostatin (SST) inhibits insulin secretion from pancreatic B-cells through a reduction of intracellular free calcium ([Ca2+]i). The influx of Ca2+ is mediated by voltage-operated Ca2+ channels (VOCCs). The role of VOCCs of the R-type (CaV2.3) in SST-mediated processes is unknown. Therefore, we designed a study to identify SST-receptor subtypes (SSTR) in insulinoma cells (INS-1) and characterize the role of t...

Objectives: Somatostatin (SST) inhibits glucagon and insulin secretion. Five receptor subtypes for SST are known (SSTR1-SSTR5), all of which are expressed in the endocrine pancreas. SSTR2 inhibits glucagon secretion in vitro, however its role in vivo is not well understood. Here, we characterize the role of SSTR2 in regulating glucose homeostasis in mice with diet-induced obesity.Methods: SSTR2-deficient (SSTR2−/−) and control mice...

Background and aim: Orexin-A (OXA) increases insulin secretion and inhibits glucagon secretion, suggesting a role in regulating glucose homeostasis. The effects of OXA on pancreatic A-cells on the cellular level have not yet been demonstrated. Aim of our study was therefore to characterise the underlying signal transduction pathways and to study the OXA effects on proglucagon gene transcription.Methods: The effects of OXA on glucagon secretion were evalu...